In this interview, Andrea Confetti highlights Dipharma’s integrated CDMO platform in the United States and Italy, supporting customers from early clinical development through scale-up and commercial manufacturing.
TWENTYFOURSEVENBIOPHARMA
In this interview, Andrea Confetti highlights Dipharma’s integrated CDMO platform in the United States and Italy, supporting customers from early clinical development through scale-up and commercial manufacturing.